RGL-270
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RGL-270, covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors [Phase 1]